Test Price
2,800 AED✅ Home Collection Available
SFTPA2 Gene Idiopathic Pulmonary Fibrosis Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SFTPA2 للتليف الرئوي مجهول السبب في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🏆 Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
🚚 Premium Logistics
Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Transport. VIP Mobile Phlebotomy available 8 AM – 11 PM daily.
📞 Clinical Guidance
Telephonic Post‑Test Clinical Guidance for result interpretation by our genetic counsellors.
💳 Insurance
Direct Billing Verification via WhatsApp at +971 54 548 8731.
دقة تشخيصية 99.9% عبر تحليل NGS معتمد من ISO. خدمة جمع عينات منزلية بسلسلة تبريد. استشارة سريرية بعد الفحص عبر الهاتف. دعم واتساب للفوترة المباشرة.
Overview
The SFTPA2 genetic test uses next‑generation sequencing to detect mutations in the surfactant protein A2 gene, which cause familial idiopathic pulmonary fibrosis (IPF). This test empowers early risk assessment and family planning, processed in our DHA‑compliant, ISO‑certified laboratory.
يستخدم تحليل جين SFTPA2 تقنية تسلسل الجيل التالي للكشف عن الطفرات المسببة للتليف الرئوي العائلي مجهول السبب، مما يتيح تقييم المخاطر المبكر والتخطيط الأسري في مختبر معتمد من هيئة الصحة بدبي.
| Feature | Our Test (NGS) | Closest Alternative (Targeted Mutation) |
|---|---|---|
| Methodology | Full‑gene Next‑Gen Sequencing with Sanger confirmation | PCR‑based hotspot analysis (limited exons) |
| Detection Rate | >99.9% of all known pathogenic variants | ~80% (misses rare or novel mutations) |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Sample Requirement | Whole Blood, Extracted DNA, or One Drop Blood on FTA Card | Whole Blood or Extracted DNA only |
| Clinical Utility | Comprehensive risk assessment, family screening, research | Basic screening for common mutations |
Physician Insight & Safety Protocol
"As a clinical care provider, I emphasise that a genetic test result alone does not define a disease; it must be interpreted alongside pulmonary function tests, imaging, and family history. Patients should never self‑interpret results without expert genetic counselling." — Dr. Prabhakar Reddy, DHA‑Licensed Specialist (ID: 61713011).
⚠️ Medication Warning: Do not discontinue or alter any prescribed medication (particularly corticosteroids or antifibrotics) based on genetic test results without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- This test is not a replacement for lung biopsy or clinical diagnosis of active IPF.
- Not offered to minors without court‑approved consent as per UAE CDS Law 2026.
- Individuals with acute respiratory distress, unexplained hemoptysis, or sudden chest pain should seek immediate emergency care — contact 998 (UAE Ambulance).
- Pregnancy or planning for prenatal diagnosis requires separate genetic counselling pre‑ and post‑test.
Patient FAQ & Clinical Guidance
What is the SFTPA2 genetic test and who should get it?
The SFTPA2 genetic test uses next-generation sequencing to detect surfactant protein A2 gene mutations causing familial idiopathic pulmonary fibrosis, recommended for patients with a family history of IPF. This includes first‑degree relatives of affected individuals, adults with early‑onset unexplained interstitial lung disease, and individuals interested in reproductive risk assessment after genetic counselling.
ما هو تحليل جين SFTPA2 ومن يجب أن يخضع له؟
تحليل جين SFTPA2 هو فحص جيني باستخدام تسلسل الجيل التالي للكشف عن الطفرات المسببة للتليف الرئوي العائلي مجهول السبب، ويُوصى به للمرضى الذين لديهم تاريخ عائلي للإصابة.
How is the test performed and what is the turnaround time?
A simple blood sample or DNA on an FTA card is collected via home phlebotomy, then analyzed with NGS technology, providing results in 3 to 4 weeks. Our certified phlebotomists visit your location in Dubai, Abu Dhabi, or any emirate between 8 AM and 11 PM. The sample is transported in a dedicated cold chain to our ISO‑accredited laboratory, and you receive secure digital results.
كيف يتم إجراء التحليل وما هي مدة النتائج؟
يتم جمع عينة دم بسيطة أو حمض نووي على بطاقة FTA عبر خدمة سحب منزلية، ثم تُحلل بتقنية NGS، وتصدر النتائج في غضون ٣ إلى ٤ أسابيع.
What do the results mean and how are they interpreted?
A positive result identifies a pathogenic SFTPA2 mutation indicating higher risk of pulmonary fibrosis, requiring clinical correlation and genetic counseling for family members. A negative result reduces but does not eliminate IPF risk; variants of uncertain significance (VUS) may need additional family studies. Our genetic counsellors provide a 30‑minute phone consultation to explain your report in context.
ماذا تعني النتائج وكيف تُفسّر؟
النتيجة الإيجابية تحدد طفرة مرضية في جين SFTPA2 تشير إلى خطر أعلى للإصابة بالتليف الرئوي، وتتطلب ترابطًا سريريًا واستشارة وراثية لأفراد العائلة.
Pre‑ Requirements
A clinical history of idiopathic pulmonary fibrosis symptoms or family history is recommended. A genetic counselling session to draw a three‑generation pedigree chart is strongly advised before sample collection. No fasting is required. If taking anticoagulants, please inform the phlebotomist.
📞 WhatsApp Support: +971 54 548 8731 | Home Collection 8 AM–11 PM | ISO 9001:2015 (INT/EGQ/2509DA/3139) | DHA Facility License 9834453
All data processing complies with UAE PDPL and Federal Decree‑Law No. 41 of 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians